WO2014162413A1 - 血液バッグシステム - Google Patents
血液バッグシステム Download PDFInfo
- Publication number
- WO2014162413A1 WO2014162413A1 PCT/JP2013/059876 JP2013059876W WO2014162413A1 WO 2014162413 A1 WO2014162413 A1 WO 2014162413A1 JP 2013059876 W JP2013059876 W JP 2013059876W WO 2014162413 A1 WO2014162413 A1 WO 2014162413A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- blood
- bag
- tube
- filter
- air
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
- A61M1/0209—Multiple bag systems for separating or storing blood components
- A61M1/0218—Multiple bag systems for separating or storing blood components with filters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2089—Containers or vials which are to be joined to each other in order to mix their contents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/22—Arrangements for transferring or mixing fluids, e.g. from vial to syringe with means for metering the amount of fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2200/00—General characteristics or adaptations
- A61J2200/70—Device provided with specific sensor or indicating means
- A61J2200/76—Device provided with specific sensor or indicating means for fluid level
Definitions
- the present invention relates to a blood bag system for preparing a blood component preparation used for blood transfusion.
- blood component preparations include erythrocyte concentrate, concentrated platelet plasma, platelet poor plasma, platelet rich plasma, and the like.
- the blood component preparation is produced by centrifuging blood from which predetermined blood cell components such as leukocytes have been removed from blood collected from a donor.
- a blood bag system used for manufacturing such a blood component preparation is described as a sterilization system in Patent Document 1, for example.
- the sterilization system of Patent Document 1 includes a first foldable container that receives blood from a donor, a filter whose housing is separated into two chambers by a filter material, a second foldable container that receives blood filtered by the filter, A first part of a fluid line led from the first foldable container to the filter and a second part of the fluid line led from the filter to the second foldable container.
- the first foldable container also includes predetermined air so that the sterilization system does not leave blood inside the filter and fluid lines.
- the sterilization system has a third foldable container disposed within the second portion of the fluid line for degassing the second foldable container.
- the predetermined amount of air included in the first foldable container is set to be larger than the capacity of the tube line portion adjacent to the filter.
- the first collapsible container will contain a total volume of air, including the volume of the filter and the volume of the first part and the second part of the fluid line, and will contain excess air.
- the 3rd foldable container is also arrange
- an excessive amount of air is mixed with blood before filtration stored in the first foldable container to induce blood activity and deteriorate the storage state of blood before filtration.
- an excessive amount of air is also mixed into the filtered blood collected in the second foldable container to induce blood activity and deteriorate the storage state of the filtered blood.
- a gas inlet and a gas outlet are provided at the inlet and outlet of the filter, and a bypass line that bypasses the filter and connects the first part and the second part of the fluid line is provided.
- An object of the present invention is to provide a blood bag system in which the yield of manufactured blood component preparation is high.
- a blood bag system includes a first bag for storing blood from a donor, a first tube for transferring blood from the first bag, a housing, and an interior of the housing.
- a filter that flows the blood after the blood outflow chamber, a second tube that transfers the filtered blood that flows out from the blood outflow chamber, and a second tube that stores the filtered blood transferred from the second tube A blood bag system, wherein the first bag contains a predetermined amount of air therein, and the air amount of the air satisfies the following expression (1).
- V1 + V2 + V3 air amount
- V4 the volume of the blood outflow chamber
- V5 represents the capacity of the second tube.
- the blood bag system may further include a third bag and a fourth bag connected to the second bag via a connecting tube.
- the air in the first bag satisfies the expression (1)
- the amount of air becomes appropriate, and blood filtration can be performed without generating an air block in the filter medium.
- the air in the first bag is sealed in the filter, and the blood remaining in the filter is pushed out to the second tube and can be collected by the second bag.
- the yield of the blood component preparation produced from the collected filtered blood is improved.
- the blood bag system of the present invention no blood remains in the filter during blood filtration, the operability is good, and the yield of the blood component preparation produced from the filtered blood is increased.
- the blood bag system 100 includes a first bag 101, a first tube 106 a, a filter 21, a second tube 106 b, and a second bag 102.
- the 1st bag 101 preserve
- the internal volume of the first bag 101 is 200 to 1000 ml.
- the first bag 101 is preferably filled with an anticoagulant such as an ACD solution or a CPD solution in advance.
- the first bag 101 includes a predetermined amount of air therein, and the air amount of the air satisfies the following expression (1).
- the air amount of the air satisfies the following expression (1).
- V1 + V2 + V3) ⁇ (air amount) ⁇ (V1 + V2 + V3 + V4 + V5)
- V1 is the capacity of the first tube 106a
- V2 is the capacity of the blood inflow chamber 28 of the filter
- V3 is the void capacity of the filter medium 27 of the filter
- V4 is the capacity of the blood outflow chamber 29 of the filter
- V5 is the first capacity.
- 2 represents the capacity of the tube 106b (see FIG. 2).
- the volume of the blood inlet chamber 28 of V2 includes the volume of the inlet 24.
- the capacity of the blood outlet chamber 29 of V4 includes the capacity of the outlet 26. Details of the filter 21, the first tube 106a, and the second tube 106b will be described later.
- the above effect cannot be obtained.
- the amount of air exceeds the upper limit value of the formula (1), air is mixed into the blood transferred from the first bag 101 to the filter 21.
- the mixed air causes an air block to be generated by the filter medium 27 at the time of blood filtration, the blood filtration is stopped, and blood remains in the filter.
- air is mixed in the pre-filtered blood stored in the first bag 101 and the filtered blood collected in the second bag 102 to induce blood activity, and the stored state of the blood before and after filtration make worse.
- the amount of air in the first bag 101 is adjusted when the blood bag system 100 is manufactured. Although not shown, blood was collected into the first bag 101 via the blood collection tube 54 using the blood bag system 100 further connected to the first bag 101 and further provided with an air bag filled with air. Later, a predetermined amount of air may be sealed in the first bag 101 from the air bag.
- a conventionally known blood collecting means is connected to the first bag 101.
- the blood collection means includes a blood collection tube 54 for supplying blood from the donor inside the first bag 101, and a puncture device 50 that punctures the donor and collects blood at the tip of the blood collection tube 54.
- the puncture device 50 includes a blood collection needle 51, a hub 52 that fixes the blood collection needle 51, and a protector 53 that covers the needle tip of the blood collection needle 51.
- the blood collection means includes a test blood bag 60 for collecting and storing the initial blood at the time of blood collection, and a conventionally known anti-puncture device 55 for preventing the blood collection needle 51 from being erroneously inserted after blood collection. Also good.
- a conventionally known blood bag 60 is used as the test blood bag 60 and is connected to a branch connector 56 provided in the middle of the blood collection tube 54 via a branch tube 58.
- the branch tube 58 is provided with a clamp 59 that closes the flow path of the branch tube 58.
- a flow path sealing member 57 is provided on the first bag 101 side of the branch connector 56 to prevent the first blood from flowing into the first bag when collecting the first blood. .
- the flow path sealing member 57 has a cover tube and a cylindrical body having a solid tip portion accommodated therein so as to close the flow path, and by breaking the solid front end portion of the cylindrical body. The flow path in the cover tube is opened.
- a sampling port 61 is connected to the test blood bag 60, and the test blood is collected through the sampling port 61 into a decompression blood collection tube (not shown).
- the sampling port 61 includes a needle assembly 62 and a holder 63 for storing the reduced-pressure blood collection tube therein and connecting the needle assembly 62 to the sampling port 61.
- the first tube 106a transfers blood from the first bag 101 to the filter 21, and one end is connected to the first bag 101 and the other end is connected to the inlet 24 (see FIG. 2) of the filter 21. .
- One end of the first tube 106 a is connected to the first bag 101 via a flow path sealing member 109 having the same configuration as the flow path sealing member 57 described above.
- the first tube 106a has a capacity V1, and the capacity V1 is the capacity of the tube from the first bag 101 to the filter 21.
- the conventionally well-known tube used for blood transfer is used for the 1st tube 106a, for example, the polyvinyl chloride tube of the same material as the 1st bag 101 is preferable.
- the filter 21 filters blood transferred from the first bag 101 via the first tube 106a to remove a predetermined blood cell component, for example, white blood cells or white blood cells and platelets from the blood.
- a predetermined blood cell component for example, white blood cells or white blood cells and platelets from the blood.
- the filter 21 includes a housing 22 and a filter medium 27 that divides the interior of the housing 22 into a blood inflow chamber 28 and a blood outflow chamber 29.
- the blood transferred from the first tube 106 a to the blood inflow chamber 28 is filtered by the filter medium 27, whereby the filtered blood from which a predetermined blood cell component has been removed flows out of the blood outflow chamber 29.
- the housing 22 has a substantially circular shape (including an oval shape) or a substantially rectangular shape in cross section along the blood flow direction.
- the housing 22 includes a bottom 23 made of polycarbonate, polyvinyl chloride, and the like, and a lid 25 having the same material and shape as the bottom 23.
- the bottom 23 has a blood inflow chamber 28 having a volume V2, and an inlet 24 that communicates with the blood inflow chamber 28 at the peripheral edge of the bottom 23.
- the capacity V2 of the blood inflow chamber 28 includes the capacity of the inflow port 24.
- the lid portion 25 has a blood outflow chamber 29 having a volume V4, and an outflow port 26 communicating with the blood outflow chamber 29 at the peripheral edge of the lid portion 25.
- the capacity V4 of the blood outflow chamber 29 includes the capacity of the outflow port 26.
- the capacity V2 and the capacity V4 are the capacity of the blood inflow chamber 28 and the blood outflow chamber 29 before blood is introduced into the filter 21 in consideration of deformation such as expansion of the housing 22 due to blood introduction.
- the filter medium 27 is made of a porous membrane made of polyurethane or the like or a nonwoven fabric made of polyethylene terephthalate or the like, and has a void volume V3.
- the porosity of the porous membrane or nonwoven fabric is preferably 40 to 99%.
- the filter medium 27 preferably has a predetermined surface zeta potential in order to improve the removal rate of a predetermined blood cell component.
- the filter 21 is manufactured by sandwiching the filter medium 27 between the bottom portion 23 and the lid portion 25 and fusing the peripheral portions of the bottom portion 23 and the lid portion 25 with ultrasonic waves, high frequencies, or the like.
- the second tube 106 b transfers filtered blood that has flowed out from the blood outflow chamber 29 of the filter 21 to the second bag 102, and one end thereof is connected to the outlet 26 of the filter 21. The other end is connected to the second bag 102. Further, the second tube 106b is provided with a clamp 105 that blocks the flow path of the second tube 106b.
- the second tube 106b has a capacity V5, and the capacity V5 is the capacity of the tube from the filter 21 to the second bag 102.
- the conventionally well-known tube used for blood transfer is used for the 2nd tube 106b, for example, the polyvinyl chloride tube of the same material as the 2nd bag 102 is preferable.
- the 2nd bag 102 preserve
- This is a bag-like container having the same shape as the bag 101.
- the second bag 102 may include a discharge port 108 for discharging the filtered blood stored in the bag 102 to the outside of the container.
- the blood bag system 100 may further include a third bag 103, a fourth bag 104, and connecting tubes 106c, 106d, and 106e in addition to the above-described configuration.
- the third bag 103 is for storing a part of the separated blood components after the filtered blood stored in the second bag is centrifuged, and a flexible resin sheet such as polyvinyl chloride is layered on the periphery. Is a bag-like container having the same shape as the first bag 101 that is fused to form a bag. Note that the third bag 103 may include a discharge port 108 for discharging blood components stored therein to the outside of the container.
- the fourth bag 104 is filled with a chemical solution such as a red blood cell preservation solution, and has the same shape as the first bag 101 in which a flexible resin sheet such as polyvinyl chloride is stacked and the periphery thereof is fused to form a bag shape. It is a bag-like container.
- the connecting tubes 106c, 106d, and 106e connect the third bag 103 and the fourth bag 104 to the second bag 102.
- the connecting tube 106c connected to the second bag 102 and the branch tube 107 to the connecting tube 106c.
- the connecting tubes 106d and 106e are connected via the.
- the connection tube 106 c has one end connected to the second bag 102 and the other end connected to the branch pipe 107.
- the connecting tube 106 c is preferably connected to the second bag 102 via the flow path sealing member 109.
- the connection tube 106 d has one end connected to the branch pipe 107 and the other end connected to the third bag 103.
- connection tube 106 e has one end connected to the branch pipe 107 and the other end connected to the fourth bag 104.
- the connecting tube 106e is preferably connected to the fourth bag 104 via the flow path sealing member 109.
- As the connecting tubes 106c, 106d, 106e, and the branch pipe 107 conventionally known tubes and pipes are used. A tube is preferred.
- the flow path sealing member 109 is as described above. In the blood bag system 100, it is preferable that a label 110 representing the contents in the bag is attached to the surface of the first bag 101, the second bag 102, the third bag 103, and the fourth bag 104. .
- the blood collection needle 51 is removed from the blood vessel of the donor, and the blood collection is terminated.
- the blood collection tube 54 and the branch tube 58 are fused and sealed using a tube sealer or the like. Thereafter, the puncture device 50 and the test blood bag 60 are separated from the first bag 101, and the puncture device 50 is discarded.
- the flow path sealing member 109 of the first tube 106a is broken to open the flow path, and the blood collected in the first bag 101 is transferred to the filter 21 via the first tube 106a. Then, the filter 21 filters white blood cells and platelets from the transferred blood. The clamp 105 of the second tube 106b is opened, and the filtered blood is transferred to the second bag 102 via the second tube 106b and collected.
- the air in the first bag 101 is sealed inside the filter 21 via the first tube 106a. Further, by arranging the filter 21 at a position above the first bag 101 and making a difference (drop) between the height of the filter 21 and the first bag 101, the air in the first bag 101 is caused by atmospheric pressure.
- the first bag 101 may be pressed to be sealed inside the filter 21 via the first tube 106a.
- a conventionally known pressing device may be used. Thereby, the blood remaining in the filter 21 is collected in the second bag 102 via the second tube 106b.
- the second bag 102 is centrifuged to separate the blood in the bag into a red blood cell layer and a plasma layer. After the flow path sealing member 109 of the connection tube 106c is opened by breakage, the plasma is transferred to the third bag 103 via the connection tubes 106c and 106d, and then the concentrated red blood cells remaining in the second bag 102 are transferred to the fourth red blood cell.
- the red blood cell preservation solution is added from the bag 104 through the connecting tubes 106c and 106e and mixed. As a result, concentrated red blood cell fluid is prepared in the second bag 102 and platelet poor plasma is prepared in the third bag 103.
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- External Artificial Organs (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Description
図1に示すように、血液バッグシステム100は、第1バッグ101と、第1チューブ106aと、フィルタ21と、第2チューブ106bと、第2バッグ102と、を備える。
第1バッグ101は、ドナーからの血液を保存するもので、ポリ塩化ビニル等の可とう性樹脂シートを重ね、その周囲を融着して袋状とした袋状容器である。また、第1バッグ101の内容量は、200~1000mlである。さらに、第1バッグ101は、その内部にACD液、CPD液等の抗凝固剤が予め充填されていることが好ましい。
(V1+V2+V3)≦(空気量)<(V1+V2+V3+V4+V5)・・・(1)
ここで、V1は第1チューブ106aの容量、V2はフィルタ21の血液流入室28の容量、V3はフィルタ21の濾材27の空隙容量、V4はフィルタ21の血液流出室29の容量、V5は第2チューブ106bの容量を表す(図2参照)。ここで、V2の血液流入室28の容量には、流入口24の容量も含まれるものとする。また、V4の血液流出室29の容量には、流出口26の容量も含まれるものとする。なお、フィルタ21、第1チューブ106a、第2チューブ106bの詳細については後記する。
第1チューブ106aは、第1バッグ101からフィルタ21に血液を移送するもので、一端が第1バッグ101に接続され、他端がフィルタ21の流入口24(図2参照)に接続されている。また、第1チューブ106aの一端は、前記した流路封止部材57と同構成の流路封止部材109を介して第1バッグ101に接続されている。また、第1チューブ106aは容量V1を有し、容量V1は第1バッグ101からフィルタ21までのチューブの容量とする。なお、第1チューブ106aには、血液移送に使用される従来公知のチューブが使用され、例えば、第1バッグ101と同材質のポリ塩化ビニルチューブが好ましい。
フィルタ21は、第1チューブ106aを介して第1バッグ101から移送される血液を濾過して、血液から所定の血球成分、例えば、白血球、または、白血球および血小板を除去する。図2に示すように、フィルタ21は、ハウジング22と、ハウジング22の内部を血液流入室28と血液流出室29とに区分けする濾材27と、を備える。そして、フィルタ21では、第1チューブ106aから血液流入室28に移送された血液を濾材27で濾過することによって、所定の血球成分が除去された濾過後の血液を血液流出室29から流出する。
図1に示すように、第2チューブ106bは、フィルタ21の血液流出室29から流出した濾過後の血液を第2バッグ102に移送するもので、一端がフィルタ21の流出口26に接続され、他端が第2バッグ102に接続されている。また、第2チューブ106bには、第2チューブ106bの流路を遮断するクレンプ105が配置されている。また、第2チューブ106bは容量V5を有し、容量V5はフィルタ21から第2バッグ102までのチューブの容量とする。なお、第2チューブ106bには、血液移送に使用される従来公知のチューブが使用され、例えば、第2バッグ102と同材質のポリ塩化ビニルチューブが好ましい。
第2バッグ102は、第2チューブ106bから移送された濾過後の血液を保存するもので、ポリ塩化ビニル等の可とう性樹脂シートを重ね、その周囲を融着して袋状とした第1バッグ101と同形状の袋状容器である。なお、第2バッグ102は、その内部に保存された濾過後の血液を容器外に排出するために排出口108を備えてもよい。
第3バッグ103は、第2バッグに保存された濾過後の血液を遠心分離後、分離した血液成分の一部を保存するもので、ポリ塩化ビニル等の可とう性樹脂シートを重ね、その周囲を融着して袋状とした第1バッグ101と同形状の袋状容器である。なお、第3バッグ103は、その内部に保存された血液成分を容器外に排出するために排出口108を備えてもよい。
第4バッグ104は、赤血球保存液等の薬液を充填するもので、ポリ塩化ビニル等の可とう性樹脂シートを重ね、その周囲を融着して袋状とした第1バッグ101と同形状の袋状容器である。
連結チューブ106c、106d、106eは、第3バッグ103、第4バッグ104を第2バッグ102に連結するもので、第2バッグ102に接続された連結チューブ106cと、その連結チューブ106cに分岐管107を介して接続された連結チューブ106d、106eとからなる。連結チューブ106cは、一端が第2バッグ102に接続され、他端が分岐管107に接続されている。なお、連結チューブ106cは、流路封止部材109を介して第2バッグ102に接続されていることが好ましい。連結チューブ106dは、一端が分岐管107に接続され、他端が第3バッグ103に接続されている。連結チューブ106eは、一端が分岐管107に接続され、他端が第4バッグ104に接続されている。なお、連結チューブ106eは、流路封止部材109を介して第4バッグ104に接続されていることが好ましい。連結チューブ106c、106d、106e、分岐管107は、従来公知のチューブ、管が使用され、例えば、第2バッグ102、第3バッグ103、第4バッグ104と同材質のポリ塩化ビニルからなるチューブ、管が好ましい。流路封止部材109は、前記した通りである。
なお、血液バッグシステム100は、第1バッグ101、第2バッグ102、第3バッグ103、第4バッグ104の表面に、バッグ内の内容物を表したラベル110が貼り付けられていることが好ましい。
22 ハウジング
27 濾材
28 血液流入室
29 血液流出室
100 血液バッグシステム
101 第1バッグ
102 第2バッグ
103 第3バッグ
104 第4バッグ
106a 第1チューブ
106b 第2チューブ
106c 連結チューブ
106d 連結チューブ
106e 連結チューブ
Claims (2)
- ドナーからの血液を保存する第1バッグと、
前記第1バッグから血液を移送する第1チューブと、
ハウジングと、前記ハウジングの内部を血液流入室と血液流出室とに区分けする濾材とを有し、前記第1チューブから前記血液流入室に移送された血液を前記濾材で濾過することによって、所定の血球成分が除去された濾過後の血液を前記血液流出室から流出するフィルタと、
前記血液流出室から流出した濾過後の血液を移送する第2チューブと、
前記第2チューブから移送された濾過後の血液を保存する第2バッグと、を備え、
前記第1バッグは、その内部に所定量の空気を含み、前記空気の空気量が以下の式(1)を満足することを特徴とする血液バッグシステム。
(V1+V2+V3)≦(空気量)<(V1+V2+V3+V4+V5)・・・(1)
ここで、V1は第1チューブの容量、V2は血液流入室の容量、V3は濾材の空隙容量、V4は血液流出室の容量、V5は第2チューブの容量を表す。 - 前記第2バッグに連結チューブを介して接続する第3バッグおよび第4バッグをさらに備えることを特徴とする請求の範囲第1項に記載の血液バッグシステム。
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015509667A JP5974164B2 (ja) | 2013-04-01 | 2013-04-01 | 血液バッグシステム |
EP13881392.8A EP2982395B1 (en) | 2013-04-01 | 2013-04-01 | Blood bag system |
US14/777,625 US20160106894A1 (en) | 2013-04-01 | 2013-04-01 | Blood Bag System |
PCT/JP2013/059876 WO2014162413A1 (ja) | 2013-04-01 | 2013-04-01 | 血液バッグシステム |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2013/059876 WO2014162413A1 (ja) | 2013-04-01 | 2013-04-01 | 血液バッグシステム |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014162413A1 true WO2014162413A1 (ja) | 2014-10-09 |
Family
ID=51657747
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2013/059876 WO2014162413A1 (ja) | 2013-04-01 | 2013-04-01 | 血液バッグシステム |
Country Status (4)
Country | Link |
---|---|
US (1) | US20160106894A1 (ja) |
EP (1) | EP2982395B1 (ja) |
JP (1) | JP5974164B2 (ja) |
WO (1) | WO2014162413A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017141950A1 (ja) * | 2016-02-16 | 2017-08-24 | テルモ株式会社 | 血液処理フィルタ及び血液バッグシステム |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3836882A4 (en) * | 2018-08-17 | 2022-05-18 | Saint-Gobain Performance Plastics Corporation | SYSTEM AND METHOD FOR STORAGE OF PHARMACEUTICAL PRODUCTS OR BIOLOGICAL MEDIA |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0540585B2 (ja) * | 1986-10-29 | 1993-06-18 | ||
JPH11216179A (ja) * | 1997-11-28 | 1999-08-10 | Terumo Corp | 白血球除去器、血液処理回路および血液処理方法 |
JP2003530171A (ja) * | 2000-04-06 | 2003-10-14 | ホワットマン ヘマシュア インコーポレーティッド | 生物学的液体を濾過するための重力駆動液体濾過システム及び方法 |
JP2008506482A (ja) | 2004-07-21 | 2008-03-06 | フレセニウス、ヘモケアー、オーストリア、ゲゼルシャフト、ミット、ベシュレンクテル、ハフツング | 密封殺菌システム、生物的または医学的流体、とりわけ全血を濾過する方法 |
JP2009517126A (ja) * | 2005-11-28 | 2009-04-30 | ヘメラス・メディカル・エルエルシー | 予充填可能な流体フィルタ処理方法及び装置 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0349188B1 (en) | 1988-06-23 | 1992-09-02 | ASAHI MEDICAL Co., Ltd. | Method for separating blood into blood components, and blood components separator unit |
US5302299A (en) * | 1990-05-24 | 1994-04-12 | Pall Corporation | Biological semi-fluid processing assembly |
CA2083075A1 (en) * | 1992-06-10 | 1993-12-11 | Vlado I. Matkovich | System for treating transition zone material |
CN1145517C (zh) * | 1998-03-20 | 2004-04-14 | 汉默卢斯医疗有限责任公司 | 白细胞减少*** |
US20060016753A1 (en) | 2002-10-25 | 2006-01-26 | Pall Corporation | Biological fluid filter |
CA2617175A1 (en) | 2005-08-05 | 2007-02-15 | Pall Corporation | Apparatus and system for displacing gas in a biological fluid processing system |
GB2473621A (en) * | 2009-09-16 | 2011-03-23 | Pall Corp | Biological fluid recovery system |
-
2013
- 2013-04-01 US US14/777,625 patent/US20160106894A1/en not_active Abandoned
- 2013-04-01 EP EP13881392.8A patent/EP2982395B1/en active Active
- 2013-04-01 JP JP2015509667A patent/JP5974164B2/ja active Active
- 2013-04-01 WO PCT/JP2013/059876 patent/WO2014162413A1/ja active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0540585B2 (ja) * | 1986-10-29 | 1993-06-18 | ||
JPH11216179A (ja) * | 1997-11-28 | 1999-08-10 | Terumo Corp | 白血球除去器、血液処理回路および血液処理方法 |
JP2003530171A (ja) * | 2000-04-06 | 2003-10-14 | ホワットマン ヘマシュア インコーポレーティッド | 生物学的液体を濾過するための重力駆動液体濾過システム及び方法 |
JP2008506482A (ja) | 2004-07-21 | 2008-03-06 | フレセニウス、ヘモケアー、オーストリア、ゲゼルシャフト、ミット、ベシュレンクテル、ハフツング | 密封殺菌システム、生物的または医学的流体、とりわけ全血を濾過する方法 |
JP2009517126A (ja) * | 2005-11-28 | 2009-04-30 | ヘメラス・メディカル・エルエルシー | 予充填可能な流体フィルタ処理方法及び装置 |
Non-Patent Citations (1)
Title |
---|
See also references of EP2982395A4 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017141950A1 (ja) * | 2016-02-16 | 2017-08-24 | テルモ株式会社 | 血液処理フィルタ及び血液バッグシステム |
Also Published As
Publication number | Publication date |
---|---|
JP5974164B2 (ja) | 2016-08-23 |
EP2982395A4 (en) | 2016-11-30 |
EP2982395A1 (en) | 2016-02-10 |
JPWO2014162413A1 (ja) | 2017-02-16 |
US20160106894A1 (en) | 2016-04-21 |
EP2982395B1 (en) | 2018-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5555356B2 (ja) | 血液バッグシステム | |
EP1267990B1 (en) | Systems and methods for collecting leukocyte-reduced blood components, including plasma that is free or virtually free of cellular blood species | |
AU2007259677A1 (en) | Blood treatment filter and blood treatment circuit | |
US7910008B2 (en) | Sealed sterile system and method for filtering biological or medical fluids, in particular whole blood | |
US8647515B2 (en) | Blood processing filter and method for priming the filter | |
JP5974164B2 (ja) | 血液バッグシステム | |
JP6072808B2 (ja) | 血液バッグ及びそれを備えた血液バッグシステム | |
JP6040307B2 (ja) | 赤血球保存液、保存液収納容器、赤血球保存液の製造方法および血液バッグシステム | |
CN202036601U (zh) | 袋式血液成份分离装置 | |
JP2015159855A (ja) | 血液バッグシステム | |
JP2001276181A (ja) | 不要物除去フィルター付血液バッグ | |
JP2022548486A (ja) | 流路封止構造、袋状容器及びその製造方法 | |
JP2015159856A (ja) | 血液バッグシステム | |
US10967111B2 (en) | Blood treatment filter and blood bag system | |
JP6267992B2 (ja) | 血液バッグシステム | |
JP2005000802A (ja) | フィルタおよび血液成分分離装置 | |
WO2017141950A1 (ja) | 血液処理フィルタ及び血液バッグシステム | |
JP6297357B2 (ja) | 血液バッグシステム | |
JPH07284518A (ja) | 血液バッグ | |
JP2005000394A (ja) | 血液成分分離装置および血液成分の分離・移送方法 | |
JP2017169780A (ja) | 血液処理回路および血液処理方法 | |
JP2013208155A (ja) | 血液成分分離用装置の姿勢保持具 | |
JP2006026327A (ja) | 体液処理回路 | |
JP2017169811A (ja) | 血液処理フィルターおよび血液処理回路 | |
JPH0724059A (ja) | 血液バツグ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13881392 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14777625 Country of ref document: US Ref document number: 2013881392 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2015509667 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |